Home / Import refusals / SCS-4494926-3/11/4

SCS-4494926-3/11/4

Cipla Limited — FEI 3004081307

Recent inspections

  • 1240813 (VAI Fri Jun 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1178952 (OAI Fri Aug 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1103305 (OAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1078911 (VAI Mon Jan 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069950 (VAI Fri Sep 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-9448937-2/10003/1 (Sat Feb 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9438325-2/40003/1 (Fri Feb 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9281602-2/10003/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9426366-0/90003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3402182-1/30003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
April 8, 2021
Country
India
Product Category
Drugs and Biologics
Product Code
62GCA99 ANTI-INFLAMMATORY N.E.C.
Charges
75